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Introduction: Chikungunya is an arthropod-borne virus endemic to Africa, Southeast Asia and India that
causes acute febrile polyarthralgia and arthritis. In this short case series, we discuss six Bangladeshi patients with
chikungunya fever. Though Bangladesh is in endemic zone, it is not common here, hence it demands attention for
proper diagnosis and management.
Case presentation: The six cases of chikungunya we report occurred in native Bangladeshi women with ages
ranging from 20 to 50 years and all having a middle class family background. Three women had severe
incapacitating arthralgia as well as a maculo-papular rash and a high fever. The other three had a high grade fever
and arthralgia only, but no rash. They were tested for chikungunya immunoglobulin M antibody and found to be
positive in all cases. They were treated symptomatically with non-steroidal anti-inflammatory drugs and found
responsive in most cases.
Conclusion: From this case series, it is evident that chikungunya is not that uncommon in Bangladesh. But the
concomitant presence of other arthropod-borne infections with similar courses of illness makes most physicians less
aware of this infection. An awareness and clinical knowledge are necessary to diagnose chikungunya infection
properly.
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Chikungunya fever is a mosquito-borne illness of humans
caused by the chikungunya virus, a type of alphavirus.
Aedes aegypti and Aedes albopictus mosquitoes are the
main vectors of chikungunya in Asia and the Indian
Ocean islands. The virus was first reported in 1952 in
Tanzania. Since then it has been attributed to many
outbreaks in a number of countries. The virus is geo-
graphically distributed in Africa, Southeast Asia and
India. Sporadic cases are regularly reported from different
countries in the affected regions [1]. During December
2008, an investigation team from the Institute of Epi-
demiology, Disease Control and Research (IEDCR) and
International Centre for Diarrhoeal Disease Research,
Bangladesh (ICDDR,B) investigated the first outbreak
of chikungunya fever in the Rajshahi and Chapianawabganj* Correspondence: rhkanak@gmail.com
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reproduction in any medium, provided the ordistricts of Bangladesh [2], which was in fact the third
outbreak [3] in the whole of Bangladesh. We identified
six cases of chikungunya fever in the last year.
Case presentation
Six cases of chikungunya fever were diagnosed last
year in a tertiary teaching hospital in Dhaka city
(Table 1). Half of our patients (three out of six) came
from different parts of Dhaka city and the rest from
different rural areas of Bangladesh. All our patients
were native Bangladeshi women and five were house-
wives. Their age ranged from 20 to 50 years. All of
them presented with severe incapacitating arthralgia
or arthritis of variable duration (two to three weeks)
with morning stiffness. They gave a history of three to
five days’ high grade fever with or without a maculo-
papular rash at the onset of illness. No one came to us
in an acute stage and initially all were treated symp-
tomatically for a common viral fever by local phy-
sicians. All patients were thoroughly examined andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Summary of findings
Findings Case-1 Case-2 Case-3 Case-4 Case-5 Case-6
Age (year) 45 45 20 35 50 42
Sex F F F F F F
Occupation Housewife Housewife Student Housewife Sousewife Housewife
Duration of fever
at onset (days) 5 3 3 5 4 6
Maculo-papular
Rash at onset Yes No Yes No Yes Yes
Arthralgia and/or Arthritis Yes Yes Yes Yes Yes Yes
ESR (mm in first hour) 65 90 50 60 30 45
RF (IU/ml) <8.1 - <8 <10 <8 <10
Anti CCP (IU/ml) <10 - <10 <11 <5 <6
Anti-chikungunya
IgM Ab +ve +ve +ve +ve +ve +ve
Residual joint pain
persisting two to three months Yes No No No No Yes
ESR, erythrocyte sedimentation rate; RF, Rheumatoid factor; Anti CCP, Anti-cyclic citrullinated peptide; IgM, Immunoglobulin M; Ab, Antibody.
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high erythrocyte sedimentation rates (ESRs) (>30mm
in the first hour). Anti-chikungunya immunoglobulin
(Ig) M antibody (Ab) was positive and serum rheuma-
toid factor (RF) and anti-citrullinated protein (CCP)
antibody were negative in all cases. They were treated
with nonsteroidal anti-inflammatory drugs (NSAIDs)
and responded well. Two of our patients had residual
joint pain for two to three months after recovering
from the initial infection.
Discussion
The name chikungunya is derived from a local language
of Tanzania meaning "that which bends up" or "stooped
walk" because of the incapacitating arthralgia caused by
the disease. Multiple outbreaks beyond West Africa have
been described. Since 2004 chikungunya has spread
widely, causing massive outbreaks with explosive onset in
the Indian Ocean region, India and other parts of Asia
[4,5]. The first outbreak in Bangladesh was observed in
December 2008 when 32 cases were identified [3]. Since
then sporadic cases were reported from different parts of
Bangladesh. Our case series is an example of sporadic chi-
kungunya infection.
The most significant manifestation of chikungunya
fever is the severe joint pain occurring in virtually
every clinical case [6]. In our cases, we observed the
same manifestation. The arthralgia is most commonly
symmetrical and peripheral, being noted in the small
joints of the hands and other large joints. The joints
exhibit extreme tenderness and swelling with patientsfrequently reporting incapacitating pain that lasts for
weeks to months. Most infections completely resolve
within weeks or months but there have been documented
cases of chikungunya fever-induced arthralgia persisting
for several years [7]. In our case series only two patients
had residual joint pain for two to three months after re-
covering from the initial infection.
The symptoms of infection are quite similar to those
caused by many other infectious agents in the endemic
areas. One particular difficulty in identifying infection is
its overlapping distribution with dengue virus. It has
been postulated that many cases of dengue virus infec-
tion are misdiagnosed and in practice the incidence of
chikungunya infection is much higher than reported [8].
Diagnosis of chikungunya is based on two cardinal signs
in the acute phase; fever and arthralgia has a specificity
of 99.6% and positive predictive value of 84.6% [9]. How-
ever, as the clinical manifestations of chikungunya fever
resemble those of dengue and other fevers caused by
arthropod-borne viruses, confirmation of chikungunya
fever should be based on: isolation of the virus, molecular
methods, detection of IgM antibody, and demonstration
of a rising titer of the IgG antibody [10]. In Bangladesh,
only detection of IgM Ab is so far possible in Dhaka city.
We confirmed our diagnosis by detecting IgM Ab against
chikungunya virus. A specific antiviral agent or vaccine
against chikungunya was not available till now. Treatment
is supportive, involving rest, proper diet, movement and
mild exercise. Combinations with mild pain relief medi-
cation, such as naproxen, ibuprofen, acetaminophen or
paracetamol, may relieve the fever and aches. Re-evaluation
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Chikungunya virus infection provides immunity against
the disease [11].
Conclusion
Chikungunya fever is not uncommon in Bangladesh as
evidenced by this short case series. Most of the cases
remain undiagnosed or misdiagnosed due to lack of
awareness and diagnostic facilities, the self-limiting na-
ture of the disease and, most importantly, the preva-
lence of another arthropod-borne disease, dengue
fever, in Bangladesh. Clinically, it can be distinguished
from dengue fever but laboratory diagnosis is a pre-
requisite for confirmation.
Consent
Written informed consents were obtained from our pa-
tients for publication of this case report. Copies of the
written consents are available for review by the Editor-
in-Chief of this journal.
Abbreviations
Ab: Antibody; Anti CCP: Anti-cyclic citrullinated peptide; ICDDR,
B: International Centre for Diarrhoeal Disease Research, Bangladesh;
IEDCR: Institute of Epidemiology, Disease Control and Research;
IgG: Immunoglobulin G; IgM: Immunoglobulin M; NSAIDs: Non-steroidal anti-
inflammatory drugs; RF: Rheumatoid factor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The first and corresponding author RH was involved in study design and
in writing the manuscript. MMR was involved in the overall supervision of
the study and writing the manuscript. MM was involved in data collection
and manuscript writing. The other authors were involved in managing
patients and data collection. All authors read and approved the final
manuscript.
Author details
1Department of Medicine, Shaheed Suhrawardy Medical College Hospital,
Dhaka, Bangladesh. 2Department of Medicine, Bangabondhu Sheikh Mujib
Medical University, Dhaka, Bangladesh.
Received: 20 May 2013 Accepted: 16 December 2013
Published: 23 February 2014
References
1. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M: Chikungunya, an
epidemic arbovirus. Lancet Infect Dis 2007, 7:319–327.
2. ICDDR B: First identified outbreak of chikungunya in Bangladesh, 2008.
Health Sci Bull 2009, 7:1.
3. Chowdhury FI, Kabir A, Das A, Mukerrama SM, Masud S: Chikungunya fever:
an emerging threat to Bangladesh. J Med 2012, 13:60–64.
4. Charrel RN, de Lamballerie X, Raoult D: Chikungunya outbreaks–the
globalization of vectorborne diseases. N Engl J Med 2007, 356:769.
5. Mavalankar D, Shastri P, Raman P: Chikungunya epidemic in India: a major
public health disaster. Lancet Infect Dis 2007, 7:306.
6. Fourie ED, Morrison JG: Rheumatoid arthritic syndrome after chikungunya
fever. S Afr Med J 1979, 56:130–132.
7. Calisher CH: Chikungunya, O’nyong nyong and Mayaro viruses
(Togaviridae). In Encyclopedia of Virology. 2nd edition. Edited by Granoff
A, Webster RG. London: Elsevier Science and Technology Books;
1999:261–265.8. Carey DE: Chikungunya and dengue: a case of mistaken identity. J Hist
Med Allied Sci 1971, 26:243–262.
9. Staikowsky F, Talarmin F, Grivard P, Souab A, Schuffenecker I, Le Roux K,
Lecuit M, Michault A: Prospective study of Chikungunya virus acute
infection in the Island of La Réunion during the 2005–2006 outbreak.
PLoS ONE 2009, 4:e7603.
10. World Health Organization: Chikungunya in South-East Asia-update. 2008.
http://209.61.208.233/en/Section10/Section2246_13975.htm.
11. Ali U, Isahak I, Rahman MM: A case report of classical chikungunya fever.
Int J Virol 2011, 7:39–41.
doi:10.1186/1752-1947-8-67
Cite this article as: Hassan et al.: Chikungunya – an emerging infection
in Bangladesh: a case series. Journal of Medical Case Reports 2014 8:67.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
